Atlas Trials

A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

Clinical trial NCT04394286 · TERMINATED

Trial details

NCT number
NCT04394286
Sponsor
Baxalta now part of Shire
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hemophilia B
Start date
2020-05-13
Primary completion
2021-05-03
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.